News
55m
Woman's World on MSNDo GLP-1 Patches Work? Get the Skinny on Natural Ozempic Alternatives
From supplements to injectables to belly-fat blasting beverages, there are plenty of products that claim to speed weight loss ...
2d
Everyday Health on MSNCan GLP-1 Patches Really Help You Lose Weight?
Experts say there’s no evidence GLP-1s can be absorbed through the skin — and these patches don’t contain the FDA-approved ...
33m
GoodRx on MSNHow to find out if weight loss drugs are covered by your insurance, and what to do if they're not
GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks.
New medicines have made weight loss easier than ever. But if you also want health and happiness, make these seven psychology ...
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.
Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...
A warning has now been issued after ‘GLP-1 weight-loss patches’ were spotted online amidst the surge in Mounjaro popularity.
A breakthrough has been made in weight-loss drugs after scientists discovered a new medication – known as TDP – that works ...
The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.
The demand for GLP-1 medications is only increasing. As employees seek better health benefits, employers who act now will set ...
1d
News-Medical.Net on MSNWhat happens to your weight after quitting GLP-1 anti-obesity drugs?
Stopping anti-obesity medications leads to significant weight regain, starting as early as eight weeks and stabilizing by six ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results